Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 211871
Company: PADAGIS US
Company: PADAGIS US
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
PODOFILOX | PODOFILOX | 0.5% | GEL;TOPICAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
11/22/2023 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
11/22/2023 | SUPPL-1 |
Label is not available on this site. |
PODOFILOX
GEL;TOPICAL; 0.5%
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
CONDYLOX | PODOFILOX | 0.5% | GEL;TOPICAL | Prescription | Yes | AB | 020529 | ALLERGAN |
PODOFILOX | PODOFILOX | 0.5% | GEL;TOPICAL | Prescription | No | AB | 211871 | PADAGIS US |